Viemed Healthcare Past Earnings Performance

Past criteria checks 2/6

Viemed Healthcare's earnings have been declining at an average annual rate of -18.4%, while the Healthcare industry saw earnings growing at 7.2% annually. Revenues have been growing at an average rate of 16.8% per year. Viemed Healthcare's return on equity is 8.3%, and it has net margins of 4.9%.

Key information

-18.4%

Earnings growth rate

-18.6%

EPS growth rate

Healthcare Industry Growth15.7%
Revenue growth rate16.8%
Return on equity8.3%
Net Margin4.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Viemed Healthcare makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:VIJ Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24214101083
30 Jun 2420691043
31 Mar 2419410983
31 Dec 2318310933
30 Sep 231709863
30 Jun 231567803
31 Mar 231466773
31 Dec 221396733
30 Sep 221338703
30 Jun 221279662
31 Mar 221219612
31 Dec 211179602
30 Sep 2111610582
30 Jun 2112011582
31 Mar 2113629621
31 Dec 2013132581
30 Sep 2012229551
30 Jun 2010829521
31 Mar 208611471
31 Dec 19809451
30 Sep 19769451
30 Jun 19738430
31 Mar 19689390
31 Dec 186410370
30 Sep 18607360
30 Jun 18569310
31 Mar 18518290
31 Dec 17478250
30 Sep 174311170
31 Dec 16311180
31 Dec 153810180
31 Dec 14239100

Quality Earnings: VIJ has high quality earnings.

Growing Profit Margin: VIJ's current net profit margins (4.9%) are lower than last year (5.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: VIJ's earnings have declined by 18.4% per year over the past 5 years.

Accelerating Growth: VIJ's earnings growth over the past year (13.3%) exceeds its 5-year average (-18.4% per year).

Earnings vs Industry: VIJ earnings growth over the past year (13.3%) did not outperform the Healthcare industry 40.5%.


Return on Equity

High ROE: VIJ's Return on Equity (8.3%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 19:27
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Viemed Healthcare, Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Doug CooperBeacon Securities Limited
Vadim MerkulovFreedom Broker
Brooks O'NeilLake Street Capital Markets, LLC